These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 26588867)

  • 1. National Trends in Utilization, Mortality, Complications, and Cost of Care After Left Ventricular Assist Device Implantation From 2005 to 2011.
    Shah N; Agarwal V; Patel N; Deshmukh A; Chothani A; Garg J; Badheka A; Martinez M; Islam N; Freudenberger R
    Ann Thorac Surg; 2016 Apr; 101(4):1477-84. PubMed ID: 26588867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-Based Differences in Left Ventricular Assist Device Utilization: Insights From the Nationwide Inpatient Sample 2004 to 2016.
    Joshi AA; Lerman JB; Sajja AP; Dahiya G; Gokhale AV; Dey AK; Kyvernitakis A; Halbreiner MS; Bailey S; Alpert CM; Poornima IG; Murali S; Benza RL; Kanwar M; Raina A
    Circ Heart Fail; 2019 Sep; 12(9):e006082. PubMed ID: 31514517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Utilization, Mortality, Major Complications, and Cost After Left Ventricular Assist Device Implantation in the United States (2009 to 2014).
    Briasoulis A; Inampudi C; Akintoye E; Adegbala O; Alvarez P; Bhama J
    Am J Cardiol; 2018 May; 121(10):1214-1218. PubMed ID: 29525059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome.
    Topilsky Y; Hasin T; Oh JK; Borgeson DD; Boilson BA; Schirger JA; Clavell AL; Frantz RP; Tsutsui R; Liu M; Maltais S; Kushwaha SS; Pereira NL; Park SJ
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):648-61. PubMed ID: 21940507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.
    Mulloy DP; Bhamidipati CM; Stone ML; Ailawadi G; Kron IL; Kern JA
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):566-73; discussion 573-4. PubMed ID: 23246055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Annual Hospital Volume on Outcomes after Left Ventricular Assist Device (LVAD) Implantation in the Contemporary Era.
    Shah N; Chothani A; Agarwal V; Deshmukh A; Patel N; Garg J; Badheka A; Martinez M; Islam N; Freudenberger R
    J Card Fail; 2016 Mar; 22(3):232-7. PubMed ID: 26547012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender Differences in Outcomes After Implantation of Left Ventricular Assist Devices.
    Ahmed A; Adegbala O; Akintoye E; Inampudi C; Ajam M; Yassin AS; Olawusi E; Shokr M; Alvarez P; Briasoulis A
    Ann Thorac Surg; 2020 Mar; 109(3):780-786. PubMed ID: 31479642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.
    Miller LW; Nelson KE; Bostic RR; Tong K; Slaughter MS; Long JW
    J Heart Lung Transplant; 2006 Jul; 25(7):778-84. PubMed ID: 16818120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation.
    Nativi JN; Drakos SG; Kucheryavaya AY; Edwards LB; Selzman CH; Taylor DO; Hertz MI; Kfoury AG; Stehlik J
    J Heart Lung Transplant; 2011 Aug; 30(8):854-61. PubMed ID: 21571550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
    Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
    J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Impact of Diabetes Mellitus on Short-Term Outcomes andIn-Hospital Mortality of Cardiac Mechanical Support with Left Ventricular Assist Device (LVAD): A Retrospective Study from a National Database.
    Yassin AS; Subahi A; Adegbala O; Abubakar H; Akintoye E; Ahmed A; Ismail A; Elhag A; Kambal A; Alade A; Shokr M; Weinberger J; Levine D; Afonso L
    Cardiovasc Revasc Med; 2019 Oct; 20(10):883-886. PubMed ID: 30578171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left Ventricular Assist Devices Impact Hospital Resource Utilization Without Affecting Patient Mortality in Gastrointestinal Bleeding.
    Li F; Hinton A; Chen A; Mehta NK; Eldika S; Zhang C; Hussan H; Conwell DL; Krishna SG
    Dig Dis Sci; 2017 Jan; 62(1):150-160. PubMed ID: 27858326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors and Outcomes of Gastrointestinal Bleeding in Left Ventricular Assist Device Recipients.
    Joy PS; Kumar G; Guddati AK; Bhama JK; Cadaret LM
    Am J Cardiol; 2016 Jan; 117(2):240-4. PubMed ID: 26651456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular complications associated with percutaneous left ventricular assist device placement: A 10-year US perspective.
    Patel N; Sharma A; Dalia T; Rali A; Earnest M; Tadros P; Wiley M; Hockstad E; Mehta A; Thors A; Hance K; Gupta K
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):309-316. PubMed ID: 31638737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
    Rogers JG; Bostic RR; Tong KB; Adamson R; Russo M; Slaughter MS
    Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.